Oxbridge Re (NASDAQ:OXBR) & Ryan Specialty (NYSE:RYAN) Critical Analysis

Oxbridge Re (NASDAQ:OXBRGet Free Report) and Ryan Specialty (NYSE:RYANGet Free Report) are both finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, dividends, earnings, profitability, risk and institutional ownership.

Valuation and Earnings

This table compares Oxbridge Re and Ryan Specialty”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Oxbridge Re $550,000.00 17.04 -$2.73 million ($0.34) -3.59
Ryan Specialty $2.52 billion 5.96 $94.67 million $0.46 123.46

Ryan Specialty has higher revenue and earnings than Oxbridge Re. Oxbridge Re is trading at a lower price-to-earnings ratio than Ryan Specialty, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

5.6% of Oxbridge Re shares are held by institutional investors. Comparatively, 84.8% of Ryan Specialty shares are held by institutional investors. 16.5% of Oxbridge Re shares are held by insiders. Comparatively, 52.2% of Ryan Specialty shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares Oxbridge Re and Ryan Specialty’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Oxbridge Re -109.74% -47.76% -29.75%
Ryan Specialty 7.61% 47.93% 5.47%

Volatility & Risk

Oxbridge Re has a beta of 1.97, suggesting that its share price is 97% more volatile than the S&P 500. Comparatively, Ryan Specialty has a beta of 0.62, suggesting that its share price is 38% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Oxbridge Re and Ryan Specialty, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oxbridge Re 1 0 1 0 2.00
Ryan Specialty 1 3 9 1 2.71

Oxbridge Re currently has a consensus target price of $5.00, indicating a potential upside of 309.84%. Ryan Specialty has a consensus target price of $68.54, indicating a potential upside of 20.69%. Given Oxbridge Re’s higher probable upside, equities analysts plainly believe Oxbridge Re is more favorable than Ryan Specialty.

Summary

Ryan Specialty beats Oxbridge Re on 12 of the 15 factors compared between the two stocks.

About Oxbridge Re

(Get Free Report)

Oxbridge Re Holdings Limited, through its subsidiaries, provides specialty property and casualty reinsurance solutions. The company underwrites collateralized reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region of the United States. It also issues reinsurance contracts through digital securities by blockchain technology. In addition, the company offers fractional aircraft ownership, jet card, aircraft brokerage, and charter service through its fleet of private aircraft. It distributes its products and solutions through reinsurance brokers. Oxbridge Re Holdings Limited was incorporated in 2013 and is headquartered in George Town, the Cayman Islands.

About Ryan Specialty

(Get Free Report)

Ryan Specialty Holdings, Inc. operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter. The company serves commercial, industrial, institutional, and government sectors. Ryan Specialty Holdings, Inc. was founded in 2010 and is headquartered in Chicago, Illinois.

Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.